{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:46:09Z","timestamp":1789076769590,"version":"build-2803163510"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1001\/jamadermatol.2020.5475","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:10:39Z","timestamp":1612973439000},"page":"348","source":"Crossref","is-referenced-by-count":10,"title":["Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy"],"prefix":"10.1001","volume":"157","author":[{"given":"Nick","family":"Thoreson","sequence":"first","affiliation":[{"name":"Boston University School of Medicine, Boston, Massachusetts"},{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"},{"name":"Beth Israel Deaconess Medical Center, Department of Dermatology, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Grasso","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Potter","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"},{"name":"Beth Israel Deaconess Medical Center, Department of Medicine, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana S.","family":"King","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Klint","family":"Peebles","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic Permanente Medical Group, Department of Dermatology, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica D.","family":"Dommasch","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health, Boston, Massachusetts"},{"name":"Beth Israel Deaconess Medical Center, Department of Dermatology, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"dld200034r1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men.","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"dld200034r2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men.","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"8","key":"dld200034r3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"dld200034r4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.det.2019.10.010","article-title":"Androgenetic alopecia in gender minority patients.","volume":"38","author":"Marks","year":"2020","journal-title":"Dermatol Clin."},{"issue":"4","key":"dld200034r5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2775818\/jamadermatology_thoreson_2021_ld_200034_1615934593.5532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T15:01:17Z","timestamp":1615993277000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2775818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5475","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}